BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain.
Z
Z
García-Casado
V
V
Traves
J
J
Bañuls
M
M
Niveiro
E
E
Gimeno-Carpio
A I
AI
Jimenez-Sanchez
M
M
Moragón
J A
JA
Onrubia
V
V
Oliver
R
R
Kumar
E
E
Nagore
D000368:Aged; D005260:Female; D020558:GTP Phosphohydrolases / Q000235:genetics*; D005838:Genotype; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics* / Q000473:pathology; D008565:Membrane Proteins / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D011446:Prospective Studies; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D044102:Receptor, Melanocortin, Type 1 / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology
D008565:Membrane Proteins; D044102:Receptor, Melanocortin, Type 1; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D020558:GTP Phosphohydrolases; C579846:NRAS protein, human